Genocea Biosciences Inc (GNCA) Investors Run for the Hills; Here’s Why

Genocea shares are plunging on termination of genital herpes treatment GEN-003.

Read more

Here’s Why Red Hat Inc (RHT) Shares Have Popped to Another Record

Red Hat’s F2Q18 results significantly beat on revenue, margin and EPS.

Read more

Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

Read more

Roth Capital Maintains Buy on First Solar, Inc. (FSLR) as ITC Vote Backs Suniva Injury Claims

201 injury found – What does it mean for First Solar?

Read more

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Announces Relaunch of Generic Depo-Provera in the US

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the reintroduction of the generic equivalent to Depo-Provera┬«1 …

Read more

Canaccord Highlights Upcoming Catalysts For Palatin Technologies, Inc. (PTN) Bulls

John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.

Read more

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety …

Read more

Valeant Pharmaceuticals Intl Inc (VRX): Analyst Louise Chen Provides Key Takeaways Following a Fireside Chat with CFO

CFO Paul Herendeen sought out to convince investors to put their money into the long game.

Read more

Here’s Why H.C. Wainwright Just Cut the Price Target for Synergy Pharmaceuticals Inc (SGYP) by 50%

Ram Selvaraju slashes his target to $8 on slower Trulance ramp.

Read more

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and HLS Therapeutics Announce Agreement to Commercialize Vascepa in Canada

Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement …

Read more